Further, the pleiotropic effectiveness of rifaximin in inflammatory bowel diseases may be related, beyond its eubiotic effect, to the regulatory properties on intestinal epithelial cells exerted through NF-κB- and pregnane X receptor-related pathways [165]. This evidence concerns the gene NR1I2 and inflammatory bowel disease.